A Phase Ib Study Investigating the Combination of RAD001 With Cisplatin and Etoposide in Patients With Extensive-Stage Small-Cell Lung Cancer Not Previously Treated With Chemotherapy.

Trial Profile

A Phase Ib Study Investigating the Combination of RAD001 With Cisplatin and Etoposide in Patients With Extensive-Stage Small-Cell Lung Cancer Not Previously Treated With Chemotherapy.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Dec 2013

At a glance

  • Drugs Everolimus (Primary) ; Cisplatin; Etoposide
  • Indications Small cell lung cancer
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 14 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Sep 2009 Planned end date (August 2010) added as reported by ClinicalTrials.gov.
    • 19 Jul 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top